Tumours overexpressing the Epithelial Growth Factor Receptor (EGFR)/HER2 are characterized by elevated PD-L1 expression, suggesting that immune escape might be, at least in part, regulated by EGFR/HER2 signalling [70,71,72]. This evidence concerns the gene EGFR and neoplasm.